Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKesson
Dow
McKinsey
Moodys
Harvard Business School
Baxter

Last Updated: May 25, 2022

Dr Reddys Company Profile


✉ Email this page to a colleague

« Back to Dashboard

Summary for Dr Reddys
International Patents:31
US Patents:5
Tradenames:209
Ingredients:197
NDAs:265

Drugs and US Patents for Dr Reddys

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd LAMOTRIGINE lamotrigine TABLET;ORAL 076708-004 Jan 27, 2009 AB RX No No See Plans and Pricing See Plans and Pricing
Dr Reddys PREGABALIN pregabalin CAPSULE;ORAL 209664-006 Jul 19, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Ltd LEVETIRACETAM levetiracetam TABLET;ORAL 076920-003 Jan 15, 2009 AB RX No No See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Inc AMVAZ amlodipine maleate TABLET;ORAL 021435-003 Oct 31, 2003 DISCN No No See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Ltd MEMANTINE HYDROCHLORIDE memantine hydrochloride TABLET;ORAL 090048-002 Apr 14, 2010 AB RX No No See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075593-004 Jun 9, 2004 AB RX No No See Plans and Pricing See Plans and Pricing
Dr Reddys LENALIDOMIDE lenalidomide CAPSULE;ORAL 209348-001 Oct 14, 2021 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Dr Reddys

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 5,834,011 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,016,652 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 4,597,961 See Plans and Pricing
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 5,834,011 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for DR REDDYS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

International Patents for Dr Reddys Drugs

Country Patent Number Estimated Expiration
Eurasian Patent Organization 201691033 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2005007188 See Plans and Pricing
European Patent Office 2457582 See Plans and Pricing
Brazil PI0412544 See Plans and Pricing
Canada 2933081 See Plans and Pricing
Brazil PI0606577 See Plans and Pricing
China 1822854 See Plans and Pricing
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Dr Reddys Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1613288 28/2011 Austria See Plans and Pricing PRODUCT NAME: FINGOLIMODHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/677-001-004 20110317
0836511 SPC/GB06/022 United Kingdom See Plans and Pricing PRODUCT NAME: FENTANYL HYDROCHLORIDE; REGISTERED: UK EU/1/05/326/001 20060124
2822954 LUC00083 Luxembourg See Plans and Pricing PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/18/1289 20180625
1769785 C300521 Netherlands See Plans and Pricing PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006
2673237 LUC00111 Luxembourg See Plans and Pricing PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326
1453521 39/2015 Austria See Plans and Pricing PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0136011 2000C/027 Belgium See Plans and Pricing PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKesson
Dow
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.